Abstract
Sexual dysfunctions are common in diabetes mellitus, both in males than in females. Diabetes is an established risk factor for sexual dysfunction in men, as a threefold increased risk of erectile dysfunction was documented in diabetic men, compared with nondiabetic men. Among women, evidence regarding the association between diabetes and sexual dysfunction is less conclusive, as female sexual function appears to be more related to social and psychological components than to the physiological consequence of diabetes. The main mechanisms by which diabetes may lead to sexual dysfunctions include vasculopathy, neuropathy, endothelial dysfunction, visceral adiposity, endocrinological disorders, and psychological issues. An adequate comprehensive sexual and medical history investigation is of paramount importance for the evaluation of sexual dysfunctions in diabetes. Moreover, standardized questionnaires are frequently used to confirm the diagnosis and to measure its severity. Two of the most practical and easily administered ones are the International Index of Erectile Function (IIEF) and its short version, the IIEF-5, and the Female Sexual Function Index (FSFI) and its short version, the FSFI-6. Therapeutic possibilities for sexual dysfunctions in diabetes refer to lifestyle changes, optimal diabetic control, psychotherapy, and selected medications when appropriated.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Corona G, Jannini EA, Maggi M. Inventories for male and female sexual dysfunctions. Int J Impot Res. 2006;18:236–50.
Dandona P, Dhindsa S. Update: hypogonadotropic hypogonadism in type 2 diabetes and obesity. J Clin Endocrinol Metab. 2011;96:2643–51.
Esposito K, Giugliano D. Obesity, the metabolic syndrome, and sexual dysfunction in men. Clin Pharmacol Ther. 2011;90:169–73.
Esposito K, Giugliano F, Di Palo C, et al. Effect of lifestyle changes on erectile dysfunction in obese men: a randomized controlled trial. JAMA. 2004;291:2978–84.
Esposito K, Ciotola M, Giugliano F, et al. Mediterranean diet improves sexual function in women with the metabolic syndrome. Int J Impot Res. 2007;19:486–91.
Esposito K, Maiorino MI, Bellastella G, Giugliano F, Romano M, Giugliano D. Determinants of female sexual dysfunction in type 2 diabetes. Int J Impot Res. 2010;22:179–84.
Giugliano F, Maiorino M, Bellastella G, Gicchino M, Giugliano D, Esposito K. Determinants of erectile dysfunction in type 2 diabetes. Int J Impot Res. 2010;22:204–9.
Hatzimouratidis K, Salonia A, Adaikan G, et al. Pharmacotherapy for erectile dysfunction: recommendations from the fourth international consultation for sexual medicine (ICSM 2015). J Sex Med. 2016;13:465–88.
Isidori AM, Pozza C, Esposito K, et al. Development and validation of a 6-item version of the female sexual function index (FSFI) as a diagnostic tool for female sexual dysfunction. J Sex Med. 2010;7:1139–46.
Katz M, DeRogatis LR, Ackerman R, Hedges P, Lesko L, Garcia M Jr, Sand M, BEGONIA trial investigators. Efficacy of flibanserin in women with hypoactive sexual desire disorder: results from the BEGONIA trial. J Sex Med. 2013;10:1807–15.
Lindau ST, Tang H, Gomero A, Vable A, Huang ES, Drum ML, Qato DM, Chin MH. Sexuality among middle-aged and older adults with diagnosed and undiagnosed diabetes: a national, population-based study. Diabetes Care. 2010;33(10):2202–10.
Maiorino MI, Bellastella G, Esposito K. Diabetes and sexual dysfunction: current perspectives. Diabetes Metab Syndr Obes. 2014;7:95–105.
Maiorino MI, Bellastella G, Esposito K. Lifestyle modifications and erectile dysfunction: what can be expected? Asian J Androl. 2015;17:5–10.
Maiorino MI, Chiodini P, Bellastella G, Giugliano D, Esposito K. Sexual dysfunction in women with cancer: a systematic review with meta-analysis of studies using the female sexual function index. Endocrine. 2016;54:329–41.
McCabe MP, Sharlip ID, Atalla E, et al. Definitions of sexual dysfunctions in women and men: a consensus statement from the fourth international consultation on sexual medicine 2015. J Sex Med. 2016;13:135–43.
Nehra A, Jackson G, Miner M, et al. The Princeton III Consensus recommendations for the management of erectile dysfunction and cardiovascular disease. Mayo Clin Proc. 2012;87:766–78.
Shamloul R, Ghanem H. Erectile dysfunction. Lancet. 2013;381(9861):153–65.
Vardi M, Nini A. Phosphodiesterase inhibitors for erectile dysfunction in patients with diabetes mellitus. Cochrane Database Syst Rev. 2007:CD002187.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Appendix 1
Appendix 1
Rights and permissions
Copyright information
© 2018 Springer International Publishing AG, part of Springer Nature
About this entry
Cite this entry
Maiorino, M.I., Bellastella, G., Esposito, K. (2018). Diabetes and Sexual Disorders. In: Bonora, E., DeFronzo, R. (eds) Diabetes Complications, Comorbidities and Related Disorders. Endocrinology. Springer, Cham. https://doi.org/10.1007/978-3-319-44433-8_16
Download citation
DOI: https://doi.org/10.1007/978-3-319-44433-8_16
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-44432-1
Online ISBN: 978-3-319-44433-8
eBook Packages: MedicineReference Module Medicine